Funded by the European Union
Department of Biotechnology Government of India

Cervical cancer prevention

In India, cervical cancer is the 2nd most common cancer in women. In 2020, more than 120,000 cases of cervical cancer were diagnosed in this country and more than 75,000 women died of this disease. Cervical Cancer affects the lower part of the uterus, which is part of the female reproductive system. This disease often starts at a young age, but the good news is that it can be prevented. Almost all cervical cancers are caused by infection with the human papillomavirus (HPV) and so getting vaccinated against HPV, before becoming sexually active, is a very effective measure to prevent cervical cancer. 

Unlike many other cancers, early identification and treatment of precancerous conditions can prevent cervical cancer. Cervical cancer screening should typically start at the age of 35. It should then be repeated periodically to detect potential threats and to start early treatment if a precancerous lesion is identified. This is why the PRESCRIP-TEC programme is making the screening process more accessible, more cost-effective, and more convenient for women in hard-to-reach areas of India.

Contact us to help you to prevent cervical cancer.

PRESCRIP-TEC: Cervical Cancer Screening

Cervical cancer kills more than 200.000 women annually worldwide and disproportionately affects the poorest, most vulnerable women in many parts of the world. Unlike many other health problems, early identification and treatment of precancerous conditions can prevent cervical cancer. As the leading cancer killer among women in the majority of developing countries, cervical cancer generally strikes women when they are young and in midlife.

Get in contact

For more information about the project you can contact us at:

Stay informed on
our latest news!

Get more information on:

This project has received funding from the European
Union’s Horizon 2020 research and innovation
programme under grant agreement No 964270